Clinical Trial Update: Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 [Phase 3]

View source ↗

Summary

Phase 3 extension study update for I10E in maintenance treatment of CIDP; terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyradiculoneuropathy

Drugs mentioned

• I10E

Snippet

Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Phase 3 | Status: TERMINATED | Results posted: 2021-04-20